Jennifer Hoskovec

Jennifer Hoskovec, VP of Clinical Affairs at Billion to One, dives into the latest breakthroughs in prenatal testing. She discusses the rise of personalized management for hemolytic disease, emphasizing non-invasive methods and cell-free DNA technology to enhance patient care. The conversation highlights a pivotal study on nipocalumab's potential to treat severe neonatal conditions and introduces innovative algorithms for managing red blood cell isoimmunization. With a focus on collaboration and accuracy, Hoskovec shares insights that could reshape obstetric practices.

Certified genetic counselor, Jen Hoskovec, discusses fetal antigen NIPT with BillionToOne. They cover topics like antigens screened, risk factors for hemolytic disease of the fetus, and the importance of genotyping in prenatal testing. The episode also touches on personalized management and the efficiency of blood type testing for medical management.